BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7521390)

  • 1. Persistent influenza C virus possesses distinct functional properties due to a modified HEF glycoprotein.
    Marschall M; Herrler G; Böswald C; Foerst G; Meier-Ewert H
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2189-96. PubMed ID: 7521390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single point mutation of the influenza C virus glycoprotein (HEF) changes the viral receptor-binding activity.
    Szepanski S; Gross HJ; Brossmer R; Klenk HD; Herrler G
    Virology; 1992 May; 188(1):85-92. PubMed ID: 1566586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The catalytic triad of the influenza C virus glycoprotein HEF esterase: characterization by site-directed mutagenesis and functional analysis.
    Pleschka S; Klenk HD; Herrler G
    J Gen Virol; 1995 Oct; 76 ( Pt 10)():2529-37. PubMed ID: 7595356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Productive and non-productive phases during long-term persistence of influenza C virus.
    Marschall M; Böswald C; Schuler A; Youzbashi E; Meier-Ewert H
    J Gen Virol; 1993 Sep; 74 ( Pt 9)():2019-23. PubMed ID: 8376976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell surface expression of biologically active influenza C virus HEF glycoprotein expressed from cDNA.
    Pekosz A; Lamb RA
    J Virol; 1999 Oct; 73(10):8808-12. PubMed ID: 10482635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-translational folding of the influenza C virus glycoprotein HEF: defective processing in cells expressing the cloned gene.
    Szepanski S; Veit M; Pleschka S; Klenk HD; Schmidt MF; Herrler G
    J Gen Virol; 1994 May; 75 ( Pt 5)():1023-30. PubMed ID: 8176364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of stearate attachment to the hemagglutinin-esterase-fusion glycoprotein HEF of influenza C virus.
    Wang M; Ludwig K; Böttcher C; Veit M
    Cell Microbiol; 2016 May; 18(5):692-704. PubMed ID: 26518983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cytoplasmic tail of the influenza C virus glycoprotein HEF negatively affects transport to the cell surface.
    Oeffner F; Klenk HD; Herrler G
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():363-369. PubMed ID: 10073696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza C virus RNA is uniquely stabilized in a steady state during primary and secondary persistent infections.
    Marschall M; Schuler A; Meier-Ewert H
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():681-6. PubMed ID: 8627256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and function of the HEF glycoprotein of influenza C virus.
    Herrler G; Klenk HD
    Adv Virus Res; 1991; 40():213-34. PubMed ID: 1957719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of anti-haemagglutinin-esterase glycoprotein monoclonal antibodies on the receptor-destroying activity of influenza C virus.
    Hachinohe S; Sugawara K; Nishimura H; Kitame F; Nakamura K
    J Gen Virol; 1989 May; 70 ( Pt 5)():1287-92. PubMed ID: 2471808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 9-O-acetylated sialic acid, a receptor determinant for influenza C virus and coronaviruses.
    Herrler G; Szepanski S; Schultze B
    Behring Inst Mitt; 1991 Jul; (89):177-84. PubMed ID: 1930096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemagglutinin-esterase-fusion (HEF) protein of influenza C virus.
    Wang M; Veit M
    Protein Cell; 2016 Jan; 7(1):28-45. PubMed ID: 26215728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent infection with an influenza C virus variant is dominantly established in the presence of the parental wild-type virus.
    Marschall M; Helten A; Hechtfischer A; Zach A; Meier-Ewert H
    Virus Res; 1998 Mar; 54(1):51-8. PubMed ID: 9660071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of individual oligosaccharide chains in antigenic properties, intracellular transport, and biological activities of influenza C virus hemagglutinin-esterase protein.
    Sugahara K; Hongo S; Sugawara K; Li ZN; Tsuchiya E; Muraki Y; Matsuzaki Y; Nakamura K
    Virology; 2001 Jun; 285(1):153-64. PubMed ID: 11414815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The receptor-destroying enzyme of influenza C virus is required for entry into target cells.
    Strobl B; Vlasak R
    Virology; 1993 Feb; 192(2):679-82. PubMed ID: 8421907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glycoprotein of influenza C virus is the haemagglutinin, esterase and fusion factor.
    Herrler G; Dürkop I; Becht H; Klenk HD
    J Gen Virol; 1988 Apr; 69 ( Pt 4)():839-46. PubMed ID: 3356980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influenza C virus glycoprotein (HE) exhibits receptor-binding (hemagglutinin) and receptor-destroying (esterase) activities.
    Vlasak R; Krystal M; Nacht M; Palese P
    Virology; 1987 Oct; 160(2):419-25. PubMed ID: 3660588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique Directional Motility of Influenza C Virus Controlled by Its Filamentous Morphology and Short-Range Motions.
    Sakai T; Takagi H; Muraki Y; Saito M
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes.
    Hanika A; Larisch B; Steinmann E; Schwegmann-Weßels C; Herrler G; Zimmer G
    J Gen Virol; 2005 May; 86(Pt 5):1455-1465. PubMed ID: 15831958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.